Free Trial

Halozyme Therapeutics (HALO) SEC Filings & 10K Form

$43.82
-0.10 (-0.23%)
(As of 05/24/2024 ET)

Recent Halozyme Therapeutics SEC Filings

DateFilerForm TypeView
05/22/2024
4:24 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:05 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
4:54 PM
Duncan Barbara Gayle (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:56 PM
Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
5:01 PM
Halozyme Therapeutics (Issuer)
Krishnan Mahesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
5:05 PM
Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
5:08 PM
Halozyme Therapeutics (Issuer)
Miyashita Akiko Moni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
5:11 PM
Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:51 PM
Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:22 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
6:22 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:38 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:46 PM
Halozyme Therapeutics (Filer)
Form ARS
03/15/2024
3:18 PM
Halozyme Therapeutics (Filer)
Form DEFA14A
03/13/2024
4:22 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:14 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
3:13 PM
Halozyme Therapeutics (Filer)
Form PRE 14A
02/28/2024
5:49 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:07 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
5:53 PM
Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:55 PM
Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:59 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:49 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:39 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:41 PM
Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:47 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
5:19 AM
Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
Form SC 13G/A
02/01/2024
2:51 PM
Halozyme Therapeutics (Subject)
Invesco Ltd. (Filed by)
Form SC 13G/A
01/17/2024
3:56 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2024
7:10 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
3:26 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
6:48 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:40 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
3:21 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
3:19 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
3:04 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:07 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2023
6:28 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
3:30 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
6:14 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:35 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Musk’s PRIME is Set to Shock the World (Ad)

Must-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing.

Click here for the full story…
08/30/2023
3:23 PM
Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
4:35 PM
Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
4:08 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:20 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
5:12 PM
Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
4:29 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
4:11 PM
Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
4:02 PM
Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
2:31 PM
Daly James M (Reporting)
Halozyme Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
5:44 PM
Daly James M (Reporting)
Halozyme Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
3:10 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:28 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/22/2023
5:20 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:36 PM
Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2023
1:15 PM
Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:HALO) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners